Bank of New York Mellon Corp Purchases 376,803 Shares of Humana Inc. $HUM

Bank of New York Mellon Corp increased its position in Humana Inc. (NYSE:HUM) by 21.9% during the 4th quarter, Holdings Channel reports. The firm owned 2,094,570 shares of the insurance provider’s stock after acquiring an additional 376,803 shares during the quarter. Bank of New York Mellon Corp’s holdings in Humana were worth $536,482,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Sound View Wealth Advisors Group LLC boosted its position in Humana by 3.5% during the 4th quarter. Sound View Wealth Advisors Group LLC now owns 1,060 shares of the insurance provider’s stock valued at $272,000 after acquiring an additional 36 shares in the last quarter. Unison Advisors LLC boosted its position in Humana by 0.4% during the 3rd quarter. Unison Advisors LLC now owns 10,137 shares of the insurance provider’s stock valued at $2,646,000 after acquiring an additional 37 shares in the last quarter. CoreCap Advisors LLC boosted its position in Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares in the last quarter. Insigneo Advisory Services LLC boosted its position in Humana by 3.0% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,484 shares of the insurance provider’s stock valued at $386,000 after acquiring an additional 43 shares in the last quarter. Finally, Columbus Macro LLC boosted its position in Humana by 5.5% during the 4th quarter. Columbus Macro LLC now owns 821 shares of the insurance provider’s stock valued at $210,000 after acquiring an additional 43 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on HUM. Raymond James Financial reaffirmed an “outperform” rating and set a $260.00 target price on shares of Humana in a research report on Friday, May 1st. Wells Fargo & Company cut Humana from a “cautious” rating to a “reduce” rating in a research report on Wednesday, May 20th. Piper Sandler reissued a “neutral” rating and issued a $254.00 price objective (up from $182.00) on shares of Humana in a research report on Wednesday, May 13th. Mizuho raised their price objective on Humana from $290.00 to $335.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 20th. Finally, The Goldman Sachs Group raised their price objective on Humana from $158.00 to $195.00 and gave the stock a “sell” rating in a research report on Thursday, April 30th. Nine analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $276.17.

Humana Stock Performance

Shares of HUM stock opened at $328.09 on Thursday. The firm has a market capitalization of $39.39 billion, a price-to-earnings ratio of 35.09, a price-to-earnings-growth ratio of 2.33 and a beta of 0.76. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. The business has a fifty day moving average of $241.36 and a 200 day moving average of $230.78. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $333.31.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm’s quarterly revenue was up 23.5% on a year-over-year basis. During the same quarter last year, the business posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, research analysts expect that Humana Inc. will post 9 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.1%. Humana’s dividend payout ratio (DPR) is presently 37.86%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.